SKIP NAVIGATION

History

The first Dental Implant in Korea. The history of Cowellmedi at a glance.

  • 1999
    • 12Entered an industrial-academic cooperation agreement with Pusan National University’s Oral and Biotechnology Research Center.
    • 11Obtained medical device manufacturing license(MFDS; Ministry of Food and Drug Safety).
      Obtained medical device manufacturing approval for its BIOPLANT Implant System (MFDS).
  • 1998
    • 09Asrahi Medical founded (CEO : Soohong Kim D.D.S. Ph.D).
  • 1994
    • 03Successfully developed localization dental implants for the first time in Korea (Soohong Kim D.D.S. Ph.D).
  • 2009
    • 01Obtained approval for clinical test plan for rhBMP-2 bone graft material(COWELLBMP)
      (MFDS; Ministry of Food and Drug Safety).
  • 2008
    • 05Completed clinical trials for rhBMP-2 bone graft material(COWELLBMP)
      (Korea University Guro Hospital, Seoul National University Bundang Hospital).
    • 01Began selling rhBMP-2 research reagents.
      Developed and began selling Sinus Lift Kit.
      Launched the sales of its products for training North Korean dentists
      (Dental Implant Products, Surgical Kits and Dental Engines).
  • 2007
    • 12Opened Seoul Branch and launched direct sales operation.
    • 07Obtained a patent for rhBMP-2 Coated Implant.
    • 05Applied for a US patent for rhBMP-2 Coated Implant.
  • 2006
    • 12Selected as an Excellent Entrepreneur (Busan Metropolitan City).
      Selected as a Leading Company in a Strategic Industry (Busan Metropolitan City).
    • 10Received the Excellent Venture Entrepreneur Award (Busan Metropolitan City).
      Established Cowellmedi Tissue Engineering Institute for Growth Factors.
    • 05Designated as a Family Firm (IBK; Industrial Bank if Korea).
  • 2005
    • 12Obtained ISO13485 Certificate.
    • 03Obtained a GMP Certificate (KGMP; Korea Good Manufacturing Practice).
  • 2004
    • 09Established R&D Center.
      Received an Excellent Small & Medium Business Award (SMBA).
      CEO Dr. Soohong Kim D.D.S. Ph.D received the Bronze Tower Order of Industrial.
      Service Merit at the 5th Innovative Technology Show.
      Obtained USFDA approval for BIOPLANT Implant System.
    • 04Selected as a Superior Technology Company (KTFC; The Korea Technology Finance Corporation).
    • 03Received an Excellent Small & Medium Business Award (SMBA).
  • 2003
    • 03Selected as an INNOBIZ Company (SMBA).
    • 01Selected as an Export-oriented Company (SMBA).
  • 2002
    • 10Selected as a Promising Export Firm (SMBA).
  • 2001
    • 04Selected as an Innovative Technology Development Company (SMBA).
  • 2000
    • 11Designated as a Venture Company (SMBA).
    • 10Selected as a Promising Export Firm (SMBA; Small & Medium Business Administration).
    • 09Obtained ISO-9001 Certification.
    • 05Converted Corporation to COWELLMEDI Co., Ltd.
  • 2019
    • 12Launched bone carrier for all procedures ’InnoGenic™ Bone Carrier’.
    • 11Held ‘COWELL® International Conference’ in Jeju, Korea.
      Certified as ‘Intellectual Property Management Enterprise’.
    • 08Launched non-resorbable membrane ‘InnoGenic™ Wifi-Mesh’.
    • 05Launched autobone harvesting kit ‘InnoGenic™ Autobone Harvester’.
    • 04Selected as Global IP(Intellectual Property) Star Corporate
      (Regional Intellectual Property Center).
    • 01Launched world’s first Beauty UP Implant.
      Launched world’s first Volume UP Implant.
  • 2018
    • 10Held ‘COWELL® International Conference’ in Prague, Czech Republic.
    • 03Held “Global Forum in Seoul”.
    • 02Launched Hurricane Bone Collector.
  • 2017
    • 11Held ‘COWELL® International Conference’ in Bangkok, Thailand.
    • 02Established overseas corporation in China and Taiwan.
  • 2016
    • 11Held ‘COWELL® International Conference’ in Seoul, Korea.
    • 07Launched INNO-CaP which bone graft material consist of Calcium Phosphate.
  • 2015
    • 10Held ‘COWELL® International Conference’ in Barcelona, Spain.
    • 03Earned approval for Mini Plus SLA Fixture as a manufactured product item(MFDS).
  • 2014
    • 12Completed the development of Bioactive surface treatment technology.
    • 11Held ‘COWELL® International Conference’ in Seoul, Korea.
    • 04Registered a domestic patent for the implant kit consisting of titanium implants and growth factors.
    • 03Registered a domestic patent for the tissue or organ regeneration kit including growth factors and membranes and scaffolds.
      Earned India’s approval and certification for INNO SLA Sub. Implant
      (CDSCO; Central Drugs Standard Control Organization).
  • 2013
    • 12Obtained USFDA approval for INNO SLA Implant System (Sub.).
    • 11Selected as a KBSI(Korea Basic Science Institute) Partner Company.
  • 2012
    • 12Obtained a CE Certification for INNO SLA Implant.
    • 05Launched INNO SLA Implant.
    • 02Obtained approval for rhBMP-2 bone graft material(COWELLBMP) spinal fusion clinical test plan (MFDS).
  • 2011
    • 02Registered US patent for rhBMP-2 Coated Implant.
  • 2010
    • 09Obtained medical device manufacturing approval for rhBMP-2 bone graft material(COWELLBMP)
      (MFDS; Ministry of Food and Drug Safety).